Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05679674 · ClinicalTrials.gov registry record · NA
Stereotactic Body Radiation and Tumor Treating Fields for Locally Advanced Pancreas Cancer
A NA study of Pancreas Cancer and Locally Advanced Pancreatic Adenocarcinoma, sponsored by Baptist Health South Florida.
- Recruiting
- Registry status
- NA
- Development phase
- 48
- Enrollment target
- 1
- Study location
NCT05679674: Recruiting NA study of Pancreas Cancer and Locally Advanced Pancreatic Adenocarcinoma, sponsored by Baptist Health South Florida.
NCT05679674 is a NA study of Pancreas Cancer and Locally Advanced Pancreatic Adenocarcinoma that is actively recruiting participants, run by Baptist Health South Florida. The registered enrollment target is 48 participants, below the 906-participant average among 54 other Pancreas Cancer trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05679674, a NA study of Pancreas Cancer and Locally Advanced Pancreatic Adenocarcinoma, is actively recruiting participants, sponsored by Baptist Health South Florida.
- RECRUITING
- Registry status
- NA
- Development phase
- 48 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this clinical trial is to determine whether using chemotherapy followed by stereotactic ablative body radiation therapy (SABR) and tumor treating fields (TTF) will slow tumor growth in people with locally advanced pancreas cancer. All participants will receive SABR therapy once per day for five days and use the TTF system for at least 18 hours per day starting on the first day of SABR until the tumor progresses or severe toxicity develops.
Primary Outcome
PFS is defined as the time from the initiation of study therapy to the first documented disease progression or death due to any cause, whichever occurs first
Conditions Studied
Interventions
- RADIATION Stereotactic Ablative Body Radiation (SABR)
- DEVICE Tumor Treating Fields (TTF)
Study Locations (1)
Florida
- Miami Cancer Institute at Baptist Health, Inc. - Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2023-09-21 |
| Est. Completion | 2027-06 |
| Phase | NA |
What NCT05679674 shows while recruiting
NCT05679674 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 48 participants, a relatively small participant target, below the 906-participant average among 54 other Pancreas Cancer trials with a reported enrollment target (95% lower).
The record links to 3 conditions, with Pancreas Cancer appearing as the primary indexed condition, and to 2 interventions - of which Stereotactic Ablative Body Radiation (SABR) is the first listed.
NCT05679674 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT05679674 about?
NCT05679674 is a clinical study titled "Stereotactic Body Radiation and Tumor Treating Fields for Locally Advanced Pancreas Cancer". The purpose of this clinical trial is to determine whether using chemotherapy followed by stereotactic ablative body radiation therapy (SABR) and tumor treating fields (TTF) will slow tumor growth in people with locally advanced pancreas cancer. All participants will receive SABR therapy once per da...
What is the current status of trial NCT05679674?
This trial is currently recruiting. It is a NA study. The enrollment target is 48 participants. The study started on 2023-09-21. Estimated completion is 2027-06.
What conditions does trial NCT05679674 study?
This clinical trial studies the following conditions: Pancreas Cancer, Locally Advanced Pancreatic Adenocarcinoma, Locally Advanced.
What interventions are being tested in trial NCT05679674?
The interventions under investigation include: Stereotactic Ablative Body Radiation (SABR) (RADIATION), Tumor Treating Fields (TTF) (DEVICE).
Who is sponsoring clinical trial NCT05679674?
This trial is sponsored by Baptist Health South Florida, which has 40 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05679674 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pancreas Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05679674's enrollment target sits among peer trials
48 32nd of 54 higher than 23 of 54 other Pancreas Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pancreas Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Stereotactic Magnetic Resonance Guided Radiation Therapy
RECRUITING · NA
-
Promoting CT Engagement for Pancreatic Cancer With App
RECRUITING · NA
-
Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes
RECRUITING · NA
-
Molecular Profile-related Individualized Targeted Therapy in Resected Pancreatic Cancer With High-Risk of Cancer Recurrence
RECRUITING · NA
-
MicroEnvironment Tumor Effects of Radiotherapy - Comprehensive Radiobiology Assessment TRial
RECRUITING · NA
-
EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer.
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01765777 · 48 participants · NA
Efficacy of Osteopathic Manipulative Medicine (OMM) and Phototherapy for Patients With Chronic Lower Back Pain
- NCT03073343 · 48 participants · NA
A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine
- NCT03431064 · 48 participants
Lung Recruitment Maneuver as a Potential Predictor of Fluid Responsiveness in Mechanically Ventilated Pediatric Patients
- NCT03514602 · 48 participants · NA
Maternal Smoking Cessation and Pediatric Obesity Prevention
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI